BCG020, a novel bispecific antibody targeting EGFR and CD70, is effective against EGFR and CD70 high expressed tumors

被引：0
|
作者：
Yang, Yongfei
Sun, Xiaoxia
Li, Ziyan
Yan, Yue
Xu, Linpeng
Wu, Xiaoxue
Du, Luheng
Zhu, Ying
Guo, Chaoshe
An, W. Frank
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2724
引用
收藏
页数：2
相关论文
共 42 条
  • [41] A phase I. first-in-human study of ARGX-110, a monoclonal antibody targeting CD70, a receptor involved in immune escape and tumor growth in patients with solid and hematologic malignancies.
    Awada, Ahmad
    Rolfo, Christian D.
    Rottey, Sylvia
    de Lendonck, Laure Ysebrant
    Schroyens, Wilfrled A.
    Offner, Fritz
    Silence, Karen
    Dreier, Torsten
    Moshir, Mahan
    de Heard, Hans
    Posters, Marc
    Bron, Dominique
    Thibault, Alain
    Aftimos, Philippe G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-EXPRESSING SOLID TUMORS WITH AFM24, A NOVEL CD16A BISPECIFIC INNATE CELL ENGAGER: COMPREHENSIVE CORRELATIVE SCIENCE FINDINGS FROM A PHASE 1 STUDY
    Hintzen, Gabriele
    Wingert, Susanne
    Emig, Michael
    Nava-Parada, Pilar
    Pietzko, Kerstin
    Kohlhas, Laura
    Reusch, Uwe
    Berrien-Elliott, Melissa
    Fehniger, Todd
    Foster, Mark
    Nuciforo, Paolo
    Castillo Andreo, Ester
    Staeble, Sina
    Ravenstijn, Paulien
    Rehbein, Bettina
    Rajkovic, Erich
    Schottelius, Arndt
    Koch, Joachim
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A762 - A762
12345